FDA Regulation Of Homeopathics Does Not Pre-empt Damages Claims – Court
This article was originally published in The Tan Sheet
Executive Summary
A federal judge rejected an argument that FDA’s regulation of homeopathic drugs pre-empts a state consumer protection law.
You may also be interested in...
Science-Based Evaluation Advocates Want Tighter Homeopathic Oversight
Public health concerns should prompt FDA to tighten its regulation of homeopathic drugs, a citizen petition filed by the nonprofit Center for Inquiry says.
“Collateral Damage” From Pharma Regs Poses Threat To Homeopathics
The biggest threat to the homeopathic drug industry is “collateral damage” from regulation of pharmaceuticals, an industry leader says.
U.K. Homeopathic Online Claims Challenged In Wider Advertising Review
The U.K. advertising regulator asks homeopathic firms to remove online claims that their products can diagnose, treat or help diseases or health conditions.